These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 1836346)
41. Progress in controlling emesis with cancer chemotherapy. Gralla RJ; Clark RA Support Care Cancer; 1993 Jul; 1(4):178-81. PubMed ID: 8193878 [TBL] [Abstract][Full Text] [Related]
42. Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity. Hesketh PJ; Gralla RJ; du Bois A; Tonato M Support Care Cancer; 1998 May; 6(3):221-7. PubMed ID: 9629873 [TBL] [Abstract][Full Text] [Related]
43. [New aspects in the antiemetic therapy of cytostatic drug-induced vomiting]. Hiller E; Gerhartz H Klin Wochenschr; 1984 May; 62(10):441-5. PubMed ID: 6748558 [TBL] [Abstract][Full Text] [Related]
44. An overview of chemotherapy-induced emesis highlighting the role of lorazepam as adjuvant therapy. Cooper R; Gent P Int J Palliat Nurs; 2002 Jul; 8(7):331-5. PubMed ID: 12165717 [TBL] [Abstract][Full Text] [Related]
45. Delayed emesis following anticancer chemotherapy. Kris MG; Roila F; De Mulder PH; Marty M Support Care Cancer; 1998 May; 6(3):228-32. PubMed ID: 9629874 [TBL] [Abstract][Full Text] [Related]
46. Ondansetron, a new antiemetic therapy for oncology. An overview. Lip H Scand J Gastroenterol Suppl; 1990; 178():55-61. PubMed ID: 2148983 [TBL] [Abstract][Full Text] [Related]
48. [Antiemetics in cytostatic-induced vomiting]. Jungmayr P Med Monatsschr Pharm; 2010 Feb; 33(2):49-54; quiz 55-6. PubMed ID: 20184263 [No Abstract] [Full Text] [Related]
49. New agents, new treatment, and antiemetic therapy. Gralla RJ Semin Oncol; 2002 Feb; 29(1 Suppl 4):119-24. PubMed ID: 11894022 [TBL] [Abstract][Full Text] [Related]
50. Corticosteroids, dopamine antagonists and other drugs. Herrstedt J; Aapro MS; Smyth JF; Del Favero A Support Care Cancer; 1998 May; 6(3):204-14. PubMed ID: 9629871 [TBL] [Abstract][Full Text] [Related]
51. Controlling emesis in patients receiving cancer chemotherapy. Gralla RJ; Kris MG; Tyson LB; Clark RA Recent Results Cancer Res; 1988; 108():89-101. PubMed ID: 3051215 [No Abstract] [Full Text] [Related]
52. The pharmacology and clinical effectiveness of phenothiazines and related drugs for managing chemotherapy-induced emesis. Wampler G Drugs; 1983 Feb; 25 Suppl 1():35-51. PubMed ID: 6840019 [No Abstract] [Full Text] [Related]
53. [Delayed vomiting after cytostatic chemotherapy]. Münstedt K; Zygmunt M Dtsch Med Wochenschr; 1998 Feb; 123(9):255-8. PubMed ID: 9524536 [No Abstract] [Full Text] [Related]
54. Tropisetron. A review of the clinical experience. de Bruijn KM Drugs; 1992; 43 Suppl 3():11-22. PubMed ID: 1380428 [TBL] [Abstract][Full Text] [Related]
55. New antiemetic drugs. Sanger GJ Can J Physiol Pharmacol; 1990 Feb; 68(2):314-24. PubMed ID: 2178755 [TBL] [Abstract][Full Text] [Related]
56. Cancer therapy, vomiting, and antiemetics. Stewart DJ Can J Physiol Pharmacol; 1990 Feb; 68(2):304-13. PubMed ID: 2178754 [TBL] [Abstract][Full Text] [Related]
57. [Prevention and management of appetite loss during cancer chemotherapy]. Tsujimura H; Yamada M; Asako E; Kodama Y; Sato T; Nabeya Y Gan To Kagaku Ryoho; 2014 Oct; 41(10):1191-5. PubMed ID: 25335699 [TBL] [Abstract][Full Text] [Related]
58. [Oncology for the general practioner--update 2007]. Cathomas R Praxis (Bern 1994); 2007 Dec; 96(50):1989-95. PubMed ID: 18179106 [TBL] [Abstract][Full Text] [Related]
59. [Use of cannabinoids for chemotherapy-induced nausea and vomiting]. Dräger DL Urologe A; 2018 Jan; 57(1):54-58. PubMed ID: 29260262 [No Abstract] [Full Text] [Related]
60. The development of future research strategies from reviewing antiemetic trials for chemotherapy induced emesis. Olver IN Rev Recent Clin Trials; 2006 Jan; 1(1):61-6. PubMed ID: 18393781 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]